Pregnolia Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.47M

  • Investors
  • 9

Pregnolia General Information

Description

Developer of a pregnancy diagnostic tool designed to detect the early changes in the cervix. The company's technology helps measure the stiffness of the cervix for accurate characterization of cervical status to mitigate the risk of the premature birth of babies and also helps with early risk detection that permits gynecologists to make key decisions about preterm birth management, enabling doctors and midwives to provide improved pregnancy care and address both the health and economic challenges of preterm birth worldwide.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Corporate Office
  • Wiesenstrasse 33
  • 8952 Schlieren
  • Switzerland
+41 044 000 00 00

Pregnolia Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pregnolia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 16-Nov-2023 $2.47M 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 25-Jun-2020 00.000 00.000 000.00 Completed Generating Revenue
3. Grant 23-Oct-2018 00.000 00.000 Completed Generating Revenue
2. Seed Round 01-Dec-2017 $3.41M $3.44M 00.000 Completed Generating Revenue
1. Accelerator/Incubator 09-Dec-2015 $29.8K $29.8K Completed Startup
To view Pregnolia’s complete valuation and funding history, request access »

Pregnolia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 102,482 $1.112663 $45.25 $45.25 1x $45.25 26.97%
Ordinary 110,651 $1.112663 $34 $34 1x $34 29.12%
To view Pregnolia’s complete cap table history, request access »

Pregnolia Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a pregnancy diagnostic tool designed to detect the early changes in the cervix. The company's technology he
Diagnostic Equipment
Schlieren, Switzerland
13 As of 2022
000.00
00.00 0000-00-00
0000000000 0 000.00

00 000

cing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
0000000000 000000000
Louisville, KY
0 As of 0000
00.000
00.00 0000-00-00
00000000000 00.000

000000

onsequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
0000000000 000000000
Little Island, Ireland
00 As of 0000
00.000
0.000 0000-00-00
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Pregnolia Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NX Prenatal Venture Capital-Backed Louisville, KY 0 00.000 00000000000 00.000
Metabolomic Diagnostics Venture Capital-Backed Little Island, Ireland 00 00.000 0000000000 0 00.000
INNITIUS Venture Capital-Backed Granada, Spain 00 000.00 0000000000 0 000.00
Sera Prognostics Formerly VC-backed Salt Lake City, UT 00 00000 00000000 00000
Tricog Health Venture Capital-Backed Bengaluru, India 000 000.00 000000 - 000 000.00
To view Pregnolia’s complete competitors history, request access »

Pregnolia Executive Team (2)

Name Title Board Seat Contact Info
Francisco Delgado Ph.D Co-Founder & Vice President of Research & Development
Sabrina Badir Ph.D Co-Founder, Chief Executive Officer & Chairwoman of the Board
To view Pregnolia’s complete executive team members history, request access »

Pregnolia Board Members (3)

Name Representing Role Since
Bruno Reihl Pregnolia Board Member 000 0000
Marc Kohler Pregnolia Board Member 000 0000
Sabrina Badir Ph.D Pregnolia Co-Founder, Chief Executive Officer & Chairwoman of the Board 000 0000
To view Pregnolia’s complete board members history, request access »

Pregnolia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pregnolia Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
3wVentures Venture Capital Minority 000 0000 000000 0
Forlam Ventures Venture Capital Minority 000 0000 000000 0
Redstone VC Venture Capital Minority 000 0000 000000 0
Stefan Gygli Angel (individual) Minority 000 0000 000000 0
Swiss Health Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »